关于先锋

Company Profile

Bioequivalence Study of Sildenafil Citrate Orally Disintegrating Tablets in Human


Release time:

2023-07-12

Indications:

For the treatment of erectile dysfunction

Test group:

1

End point indicators:

1

Number of subjects:

Serial number

Enterprise

Number of subjects

1

Anhui Pioneer Pharmaceutical Co., Ltd.

24 cases

2

Shandong Langnuo Pharmaceutical Co., Ltd.

36 cases

3

Yunnan Longjin Kangyou Biological Medicine Co., Ltd.

40 cases

4

Jinhong Pharmaceutical Co., Ltd.

40 cases

5

Shandong Huabo Kaisheng Biotechnology Co., Ltd.

36 cases

6

Nanjing Changao Pharmaceutical Co., Ltd.

40 cases

7

Zhejiang Xinrui Pharmaceutical Co., Ltd.

48 cases

8

Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd.

36 cases

9

Beijing Xinghao Pharmaceutical Co., Ltd.

24 cases

10

Qilu Pharmaceutical Co., Ltd.

42 cases

11

Renhe Yikang Group Co., Ltd.

36 cases

12

Tiandi Hengyi Pharmaceutical Co., Ltd.

36 cases

13

Zhejiang Baiao Pharmaceutical Technology Co., Ltd.

36 cases

14

Shandong Huabo Kaisheng Biotechnology Co., Ltd.

36 cases

15

Jingshi (Hangzhou) Pharmaceutical Co., Ltd.

32 cases

16

Hebei Longhai Pharmaceutical Co., Ltd.

40 cases

17

Guangdong Zhongrun Drug Research and Development Co., Ltd.

40 cases

18

Hangzhou Heze Kunyuan Pharmaceutical Co., Ltd.

39 cases

19

Jiangxi Shimei Pharmaceutical Co., Ltd.

39 cases

20

Sichuan Kelun Pharmaceutical Co., Ltd.

36 cases

Back →